Medicine library

Browse medicines

Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.

Showing 1–60 of 74 records

Semaglutide (Ozempic / Wegovy / Rybelsus)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, obesity, and heart and kidney risk that comes with them
Melanotan II (No trade name; sold as MT-II or MT2, by injection and as a nasal spray)
Peptide medicineControlled substance; no approved US useDetailed record
Use listed on the medicine record
Tanning without sun — unlicensed everywhere, with no approved use
Desmopressin (DDAVP / Stimate / Nocdurna / Noctiva)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Passing far too much urine because the body is missing the hormone that concentrates it — and, separately, bleeding in mild haemophilia A or mild von Willebrand disease
Ipamorelin (Also written NNC 26-0161. No trade name; never marketed)
Peptide medicineIn Phase 2 testingDetailed record
Use listed on the medicine record
A growth hormone releaser designed to leave cortisol alone — never approved
Epitalon (Also written Epithalon and AEDG peptide. Distinct from Epithalamin, the bovine pineal extract it was derived from)
Peptide medicineLaboratory or animal-stage researchDetailed record
Use listed on the medicine record
A four-amino-acid anti-ageing peptide with no clinical trial anywhere
Liraglutide (Victoza / Saxenda)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes and long-term weight management
Dulaglutide (Trulicity)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, including in people who have not yet had a heart attack
Exenatide (Byetta / Bydureon / Bydureon BCise)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes
Teriparatide (Forteo / Bonsity)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Severe bone thinning, where the aim is to build new bone rather than only slow its loss
Tirzepatide (Mounjaro / Zepbound)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, obesity, and obesity-related sleep apnoea
Retatrutide (LY3437943 (no trade name; not approved))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Obesity and type 2 diabetes, still in trials
Sermorelin (Geref, Geref Diagnostic (both discontinued))
Peptide medicineWithdrawn from the marketDetailed record
Use listed on the medicine record
A childhood growth drug that was approved, then pulled — now compounded for anti-ageing
Survodutide (BI 456906 (no trade name; not approved))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Obesity and fatty liver disease, still in trials
CJC-1295 (CJC-1295 with DAC. The product sold as "CJC-1295 without DAC" is a different molecule, modified GRF(1-29))
Peptide medicineIn Phase 2 testingDetailed record
Use listed on the medicine record
Raises growth hormone for a week per injection — no approved use anywhere
TB-500 (thymosin beta-4) (Sold as TB-500. The full peptide is thymosin beta-4, developed as RGN-259 (eye drops) and NL005 (recombinant injection))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Sold for injury repair — nothing containing it is approved anywhere
Selank (Selank; the peptide is written Thr-Lys-Pro-Arg-Pro-Gly-Pro)
Peptide medicineDietary supplement; not FDA-approved as a medicineDetailed record
Use listed on the medicine record
A Russian anti-anxiety peptide, sold elsewhere as a nasal spray research chemical
Semax (Semax; the peptide is written ACTH(4-7)PGP or Met-Glu-His-Phe-Pro-Gly-Pro)
Peptide medicineDietary supplement; not FDA-approved as a medicineDetailed record
Use listed on the medicine record
A Russian stroke and nootropic peptide, sold elsewhere as a nasal spray research chemical
Abaloparatide (Tymlos)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors
Octreotide (Octreotide Acetate (Preservative Free) / Sandostatin / Octreotide Acetate Preservative Free / Mycapssa / Sandostatin Lar / Bynfezia)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Profuse watery diarrhea associated with VIP-secreting tumors
Ecallantide (Kalbitor)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Treatment of acute attacks of hereditary angioedema
Elamipretide (Forzinity)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Muscle strength
Eptifibatide (Integrilin)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Eptifibatide injection is a platelet aggregation inhibitor indicated for: • Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI) ( 1.1 ) • Treatment of patients undergoing PCI (including intracoronary stenting) ( 1.2 ) 1.1 Acute Coronary Syndrome (ACS) Eptifibatide injection is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstable angina [UA]/non-ST- elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those undergoing…
Albiglutide (Tanzeum)
Peptide medicineApproved in the United States (FDA)Expanded record
Defibrotide (Defitelio)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). DEFITELIO is indicated for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT). ( 1 )
Goserelin (Zoladex)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Locally confined carcinoma of the prostate ( 1
Lixisenatide (Adlyxin)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Diabetic ketoacidosis
Lanreotide (Somatuline Depot)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tu
Oxytocin (Pitocin / Syntocinon / Oxytocin 10 USP Units in Dextrose 5% / Oxytocin 5 USP Units in Dextrose 5% / Oxytocin 20 USP Units in Dextrose 5%)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
The medical rather than the elective induction of labor
Ziconotide (Prialt)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Severe chronic pain
Vasopressin (Vasostrict / Vasopressin in Sodium Chloride 0.9% / Vasopressin in 0.9% Sodium Chloride / Vasopressin in Dextrose 5% / Pitressin Tannate)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Blood pressure
Tesamorelin (Egrifta)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Excess abdominal fat in HIV-infected adult patients with lipodystrophy
Etelcalcetide (Parsabiv)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Secondary hyperparathyroidism
Flavin Adenine Dinucleotide (Enbrace Hr / Paxlyte)
Peptide medicineUsed in a way not covered by an approval, or made by a compounding pharmacyExpanded record
Use listed on the medicine record
INDICATIONS: EnBrace HR ® is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B 12 deficiency, and the PREVENTION of vitamin B 12 -cofactor deficiency, l-methylfolate. Requirements of vitamin B 9 and/or vitamin B 12 in excess of normal due to pregnancy can usually be met with oral supplementation.
Lypressin (Diapid)
Peptide medicineApproved in the United States (FDA)Expanded record
Pramlintide (Symlin / Symlinpen)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Type 1 or type 2 diabetes who use mealtime insulin and have failed to achieve desired glycemic control despite optimal insulin therapy
Betiatide (Technetium Tc 99m Mertiatide / Kit For the Preparation of Technetium Tc99m Mertiatide / Technescan Mag3)
Peptide medicineLaboratory or animal-stage researchExpanded record
Use listed on the medicine record
The diagnosis of congenital and acquired renal abnormalities, renal failure, urinary tract obstruction, and calculi
Bulevirtide (Hepcludex)
Peptide medicineLaboratory or animal-stage researchExpanded record
Use listed on the medicine record
Chronic hepatitis delta virus (HDV) infection
Corticorelin (Hp Axis)
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Use listed on the medicine record
• For the temporary relief of symptoms including: • circadian rhythm support • sleep problems • circulatory support • anxiety • overuse of stimulants • decreased sex drive • salt cravings These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Gallium Ga-68 Gozetotide (Gallium Ga-68 Psma-11 / Gozellix / Locametz / Illuccix)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions
Lactotripeptide
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Lutrelin (Guna-Geriatrics)
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Use listed on the medicine record
TAKE 15 MINUTES BEFORE MEALS
Bremelanotide (Vyleesi (Autoinjector) / Vyleesi)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: A co-existing medical or psychiatric condition, Problems with the relationship, or The effects of a medication or drug substance. Acquired HSDD refers to HSDD that develops in a patient who previously had no problems with sexual desire. Generalized HSDD refers to HSDD that occurs regardless of the type of stimulation, situation or partner.
Crocin
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Macimorelin (Macrilen)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
The diagnosis of adult growth hormone deficiency
Motixafortide (Aphexda)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
APHEXDA is indicated in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma. APHEXDA, a hematopoietic stem cell mobilizer, is indicated in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma. ( 1 )
Nafarelin (Synarel)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Treatment of central precocious puberty
Nesiritide (Natrecor)
Peptide medicineApproved in the United States (FDA)Expanded record
Novobiocin (Albamycin)
Peptide medicineApproved in the United States (FDA)Expanded record
Palopegteriparatide (Yorvipath)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Hypoparathyroidism
Peginesatide (Omontys Preservative Free / Omontys)
Peptide medicineApproved in the United States (FDA)Expanded record
Afamelanotide (Scenesse)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Pain free light exposure
Capromab Pendetide (Prostascint)
Peptide medicineApproved in the United States (FDA)Expanded record
Enfuvirtide (Fuzeon)
Peptide medicineApproved in the United States (FDA)Expanded record
Gonadorelin (Factrel / Lutrepulse Kit)
Peptide medicineApproved in the United States (FDA)Expanded record
Histrelin (Supprelin / Vantas)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Central precocious puberty
Linaclotide (Linzess)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
LINZESS is indicated for the treatment of: • irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older • chronic idiopathic constipation (CIC) in adults • functional constipation (FC) in pediatric patients 2 years of age and older LINZESS is a guanylate cyclase-C agonist indicated for treatment of: Irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older. ( 1 ) Chronic idiopathic constipation (CIC) in adults. ( 1 ) Functional constipation (FC) in pediatric patients 2 years of age and older.
Navepegritide (Yuviwel)
Peptide medicineApproved in the United States (FDA)Expanded record
Use listed on the medicine record
Linear growth
Nicotinamide Adenine Dinucleotide (Virexa)
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Use listed on the medicine record
Virexa is a multivitamin with folic acid dispensed by prescription only.
Nicotinamide Mononucleotide
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record
Oligopeptide
Peptide medicineDietary supplement; not FDA-approved as a medicineExpanded record

Semaglutide (Ozempic / Wegovy / Rybelsus)

Melanotan II (No trade name; sold as MT-II or MT2, by injection and as a nasal spray)

Desmopressin (DDAVP / Stimate / Nocdurna / Noctiva)

Ipamorelin (Also written NNC 26-0161. No trade name; never marketed)

Epitalon (Also written Epithalon and AEDG peptide. Distinct from Epithalamin, the bovine pineal extract it was derived from)

Liraglutide (Victoza / Saxenda)

Dulaglutide (Trulicity)

Exenatide (Byetta / Bydureon / Bydureon BCise)

Teriparatide (Forteo / Bonsity)

Tirzepatide (Mounjaro / Zepbound)

Retatrutide (LY3437943 (no trade name; not approved))

Sermorelin (Geref, Geref Diagnostic (both discontinued))

Survodutide (BI 456906 (no trade name; not approved))

CJC-1295 (CJC-1295 with DAC. The product sold as "CJC-1295 without DAC" is a different molecule, modified GRF(1-29))

TB-500 (thymosin beta-4) (Sold as TB-500. The full peptide is thymosin beta-4, developed as RGN-259 (eye drops) and NL005 (recombinant injection))

Selank (Selank; the peptide is written Thr-Lys-Pro-Arg-Pro-Gly-Pro)

Semax (Semax; the peptide is written ACTH(4-7)PGP or Met-Glu-His-Phe-Pro-Gly-Pro)

Abaloparatide (Tymlos)

Octreotide (Octreotide Acetate (Preservative Free) / Sandostatin / Octreotide Acetate Preservative Free / Mycapssa / Sandostatin Lar / Bynfezia)

Ecallantide (Kalbitor)

Elamipretide (Forzinity)

Eptifibatide (Integrilin)

Albiglutide (Tanzeum)

Defibrotide (Defitelio)

Goserelin (Zoladex)

Lixisenatide (Adlyxin)

Lanreotide (Somatuline Depot)

Oxytocin (Pitocin / Syntocinon / Oxytocin 10 USP Units in Dextrose 5% / Oxytocin 5 USP Units in Dextrose 5% / Oxytocin 20 USP Units in Dextrose 5%)

Ziconotide (Prialt)

Vasopressin (Vasostrict / Vasopressin in Sodium Chloride 0.9% / Vasopressin in 0.9% Sodium Chloride / Vasopressin in Dextrose 5% / Pitressin Tannate)

Tesamorelin (Egrifta)

Etelcalcetide (Parsabiv)

Flavin Adenine Dinucleotide (Enbrace Hr / Paxlyte)

Lypressin (Diapid)

Pramlintide (Symlin / Symlinpen)

Betiatide (Technetium Tc 99m Mertiatide / Kit For the Preparation of Technetium Tc99m Mertiatide / Technescan Mag3)

Bulevirtide (Hepcludex)

Corticorelin (Hp Axis)

Gallium Ga-68 Gozetotide (Gallium Ga-68 Psma-11 / Gozellix / Locametz / Illuccix)

Lactotripeptide

Lutrelin (Guna-Geriatrics)

Bremelanotide (Vyleesi (Autoinjector) / Vyleesi)

Crocin

Macimorelin (Macrilen)

Motixafortide (Aphexda)

Nafarelin (Synarel)

Nesiritide (Natrecor)

Novobiocin (Albamycin)

Palopegteriparatide (Yorvipath)

Peginesatide (Omontys Preservative Free / Omontys)

Afamelanotide (Scenesse)

Capromab Pendetide (Prostascint)

Enfuvirtide (Fuzeon)

Gonadorelin (Factrel / Lutrepulse Kit)

Histrelin (Supprelin / Vantas)

Linaclotide (Linzess)

Navepegritide (Yuviwel)

Nicotinamide Adenine Dinucleotide (Virexa)

Nicotinamide Mononucleotide

Oligopeptide